He joined Gilde in 2003 following the acquisition by Xenova Group of KS Biomedix, a UK quoted biotech company of which he had been CEO since 1999.
Dr Steven Powell was CEO of Plethora Solutions Holdings, a biotech company listed on AIM (London).
Previously, he served in a variety of technical and commercial management roles with pharmaceutical and biotechnology companies.
Dr Powell graduated in Microbiology from the University of Wales and was awarded a PhD from the University of Aberdeen.
He is a UK national.